Early Access

Back to BMY

BRISTOL MYERS SQUIBB CO Cash & Equivalents 2006-2025 | BMY

Beta

What is cash & equivalents?

Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.

What is BRISTOL MYERS SQUIBB CO's current cash & equivalents?

BRISTOL MYERS SQUIBB CO (BMY) annual cash & equivalents for 2025 was $10.21B, a 1.32% decline from 2024. BRISTOL MYERS SQUIBB CO cash & equivalents for the quarter ending December 31, 2025 was $10.21B.

What was BRISTOL MYERS SQUIBB CO's cash & equivalents in 2024?

BRISTOL MYERS SQUIBB CO annual cash & equivalents for 2024 was $10.35B, a 9.75% decline from 2023.

What was BRISTOL MYERS SQUIBB CO's cash & equivalents in 2023?

BRISTOL MYERS SQUIBB CO annual cash & equivalents for 2023 was $11.46B, a 25.66% increase from 2022.

What is BRISTOL MYERS SQUIBB CO's 5-year cash & equivalents CAGR?

BRISTOL MYERS SQUIBB CO cash & equivalents grew at a compound annual growth rate (CAGR) of 6.84% from FY2020 to FY2025, going from $14.55B to $10.21B over 5 years.

Cash & Equivalents History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR-6.8%
FY2020
$14.55B
FY2025
$10.21B
0607080910111213141516171819202122232425
5 years selected
Cash & Equivalents History
PeriodValueChangeSource
FY2025$10.21B-1.3%10-K
FY2024$10.35B-9.8%10-K
FY2023$11.46B+25.7%10-K
FY2022$9.12B-34.7%10-K
FY2021$13.98B-3.9%10-K
FY2020$14.55B+17.8%10-K
FY2019$12.35B+78.6%10-K
FY2018$6.91B+27.5%10-K
FY2017$5.42B+27.9%10-K
FY2016$4.24B+77.7%10-K
FY2015$2.38B-57.2%10-K
FY2014$5.57B+55.4%10-K
FY2013$3.59B+116.5%10-K
FY2012$1.66B-71.3%10-K
FY2011$5.78B+14.8%10-K
FY2010$5.03B-34.5%10-K
FY2009$7.68B-3.7%10-K
FY2008$7.98B+342.9%10-K
FY2007$1.80B-10.8%10-K
FY2006$2.02B-10-K
Company: BRISTOL MYERS SQUIBB COTicker: BMYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →